Sfoglia per Rivista CANCER CELL
Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation.
2010-01-01 Liang, K; Esteva, Fj; Albarracin, C; Stemke-Hale, K; Lu, Y; Bianchini, G; Yang, Cy; Li, Y; Li, X; Chen, Ct; Mills, Gb; Hortobagyi, Gn; Mendelsohn, J; Hung, Mc; Fan, Z
Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.
2011-01-01 Mazzieri, R; Pucci, F; Moi, D; Zonari, E; Ranghetti, A; Berti, A; Politi, Ls; Gentner, B; Brown, Jl; Naldini, Luigi; De Palma, M.
Targeting the tumor and its microenvironment by a dual-function decoy met receptor
2004-01-01 Michieli, P.; Mazzone, M.; Basilico, C.; Cavassa, S.; Sottile, A.; Naldini, Luigi; Comoglio, P. M.
The differentiation and stress response factor, XBP-1, drives multiple myeloma pathogenesis
2007-01-01 Carrasco, Dr; Sukhdeo, K; Protopopova, M; Sinha, R; Enos, M; Carrasco, De; Zheng, M; Mani, M; Henderson, J; Pinkus, Gs; Munshi, N; Horner, J; Ivanova, Ev; Protopopov, A; Anderson, Kc; Tonon, G; Depinho, Ra
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors
2005-01-01 DE PALMA, M.; Venneri, M. A.; Galli, R.; SERGI SERGI, L.; Politi, L. S.; Sampaolesi, M.; Naldini, Luigi
Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling
2016-01-01 Zhang, Xing-Ding; Baladandayuthapani, Veerabhadran; Lin, Heather; Mulligan, George; Li, Bin; Esseltine, Dixie-Lee W; Qi, Lin; Xu, Jianliang; Hunziker, Walter; Barlogie, Bart; Usmani, Saad Z; Zhang, Qing; Crowley, John; Hoering, Antje; Shah, Jatin J; Weber, Donna M; Manasanch, Elisabet E; Thomas, Sheeba K; Li, Bing-Zong; Wang, Hui-Han; Zhang, Jiexin; Kuiatse, Isere; Tang, Jin-Le; Wang, Hua; He, Jin; Yang, Jing; Milan, Enrico; Cenci, Simone; Ma, Wen-Cai; Wang, Zhi-Qiang; Davis, Richard Eric; Yang, Lin; Orlowski, Robert Z
Transformation of normal human cells in the absence of telomerase activation
2002-01-01 Seger, Yr; Garcia Cao, M; Piccinin, S; Cunsolo, Cl; Doglioni, Claudio; Blasco, Ma; Hannon, Gj; Maestro, R.
Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis
2008-01-01 De Palma, M; Mazzieri, R; Politi, L. S.; Pucci, F; Zonari, E; Sitia, G; Mazzoleni, S.; Moi, D; Venneri, M; Indraccolo, S; Falini, A; Guidotti, L; Galli, R; Naldini, L
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. | 1-gen-2010 | Liang, K; Esteva, Fj; Albarracin, C; Stemke-Hale, K; Lu, Y; Bianchini, G; Yang, Cy; Li, Y; Li, X; Chen, Ct; Mills, Gb; Hortobagyi, Gn; Mendelsohn, J; Hung, Mc; Fan, Z | |
| Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. | 1-gen-2011 | Mazzieri, R; Pucci, F; Moi, D; Zonari, E; Ranghetti, A; Berti, A; Politi, Ls; Gentner, B; Brown, Jl; Naldini, Luigi; De Palma, M. | |
| Targeting the tumor and its microenvironment by a dual-function decoy met receptor | 1-gen-2004 | Michieli, P.; Mazzone, M.; Basilico, C.; Cavassa, S.; Sottile, A.; Naldini, Luigi; Comoglio, P. M. | |
| The differentiation and stress response factor, XBP-1, drives multiple myeloma pathogenesis | 1-gen-2007 | Carrasco, Dr; Sukhdeo, K; Protopopova, M; Sinha, R; Enos, M; Carrasco, De; Zheng, M; Mani, M; Henderson, J; Pinkus, Gs; Munshi, N; Horner, J; Ivanova, Ev; Protopopov, A; Anderson, Kc; Tonon, G; Depinho, Ra | |
| Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors | 1-gen-2005 | DE PALMA, M.; Venneri, M. A.; Galli, R.; SERGI SERGI, L.; Politi, L. S.; Sampaolesi, M.; Naldini, Luigi | |
| Tight Junction Protein 1 Modulates Proteasome Capacity and Proteasome Inhibitor Sensitivity in Multiple Myeloma via EGFR/JAK1/STAT3 Signaling | 1-gen-2016 | Zhang, Xing-Ding; Baladandayuthapani, Veerabhadran; Lin, Heather; Mulligan, George; Li, Bin; Esseltine, Dixie-Lee W; Qi, Lin; Xu, Jianliang; Hunziker, Walter; Barlogie, Bart; Usmani, Saad Z; Zhang, Qing; Crowley, John; Hoering, Antje; Shah, Jatin J; Weber, Donna M; Manasanch, Elisabet E; Thomas, Sheeba K; Li, Bing-Zong; Wang, Hui-Han; Zhang, Jiexin; Kuiatse, Isere; Tang, Jin-Le; Wang, Hua; He, Jin; Yang, Jing; Milan, Enrico; Cenci, Simone; Ma, Wen-Cai; Wang, Zhi-Qiang; Davis, Richard Eric; Yang, Lin; Orlowski, Robert Z | |
| Transformation of normal human cells in the absence of telomerase activation | 1-gen-2002 | Seger, Yr; Garcia Cao, M; Piccinin, S; Cunsolo, Cl; Doglioni, Claudio; Blasco, Ma; Hannon, Gj; Maestro, R. | |
| Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis | 1-gen-2008 | De Palma, M; Mazzieri, R; Politi, L. S.; Pucci, F; Zonari, E; Sitia, G; Mazzoleni, S.; Moi, D; Venneri, M; Indraccolo, S; Falini, A; Guidotti, L; Galli, R; Naldini, L |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile